Rofecoxib Attenuates the Pathogenesis of Amyotrophic Lateral Sclerosis by Alleviating Cyclooxygenase-2-Mediated Mechanisms. This evidence concerns the gene PTGS2 and amyotrophic lateral sclerosis.